Differential function of major histocompatibility complex antigens in T-lymphocyte activation - PubMed (original) (raw)
Review
. 1976 Jan 29;259(5541):273-81.
doi: 10.1038/259273a0.
- PMID: 129707
- DOI: 10.1038/259273a0
Review
Differential function of major histocompatibility complex antigens in T-lymphocyte activation
F H Bach et al. Nature. 1976.
Abstract
We have emphasised the functional dichotomy of MHC LD and LD antigens as well as the differences in cellular responses to these antigens. Perhaps in so doing we have failed to stress adequately the similarities that exist. But while the similarities (for example skin graft rejection associated with both K and I region differences) are so very clear, the differences have best allowed our progressive understanding of MHC induced cellular responses from the perspective stressed in this article. Of greatest importance to our understanding of these transplantation antigens are the potentially differential roles for the LD and SD antigens in the complex series of events that are collectively referred to as the "allograft reaction". It has been suggested that these differences may be "merely quantitative". This possibility has been discussed repeatedly in our previous reports on the distinction of LD and SD. In fact, the great bulk of biological phenomena can be reduced to quantitative differences. It would seem to us that sufficient evidence for such differential activity exists to make the LD-SD dichotomy model an heuristically valuable one for purposes of designing future experiments. We have discussed the clinical relevance of this model elsewhere. Many authors have speculated and evidence has been gathered to suggest, that cell surface antigens associated with the MHC are important in developmental and other cell interactions. Some studies have directly addressed the question of the need for MHC compatibility to allow cell interaction to proceed optimally. It thus seems most appropriate that the genetic complex with which we are dealing has been termed the major histocompatibility complex; allowing for the literal interpretation of this term this may be the genetic region that by its influence on "tissue compatibility" may control critical cellular interactions in addition to those observed in allograft reactions. It is the simple good fortune for those whose attention was focused on this complex by transplantation problems to find themselves with a panorama of biological phenomena that require extensive experimental probing and integration, hopefully ultimately leading to an understanding of the MHC in a broader context than has to date been possible.
Similar articles
- Genetics of transplantation: the major histocompatibility complex.
Bach FH. Bach FH. Annu Rev Genet. 1976;10:319-39. doi: 10.1146/annurev.ge.10.120176.001535. Annu Rev Genet. 1976. PMID: 138383 - Genetic and cellular control of in vitro models of allograft reactivity.
Bach FH, Alter BJ, Schendel DJ, Segall M, Bach ML. Bach FH, et al. Birth Defects Orig Artic Ser. 1975;11(1):467-76. Birth Defects Orig Artic Ser. 1975. PMID: 238687 - Genetic control of major complex histocompatibility antigens.
Bcah FH. Bcah FH. Genetics. 1975 Jun;79 Suppl:263-75. Genetics. 1975. PMID: 125215 - Differential cellular immune responsiveness to systems of the major histocompatibility complex.
Bach FH. Bach FH. J Allergy Clin Immunol. 1976 Feb;57(2):95-111. doi: 10.1016/0091-6749(76)90029-4. J Allergy Clin Immunol. 1976. PMID: 55429 Review. - The use of H-2 mutants as models for the study of T cell activation.
McKenzie IF, Pang T, Blanden RV. McKenzie IF, et al. Immunol Rev. 1977;35:179-230. Immunol Rev. 1977. PMID: 70397 Review. No abstract available.
Cited by
- Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses.
Su C, Yang JC, Rong Z, Li F, Luo LX, Liu G, Cheng CY, Zhao MG, Yang L. Su C, et al. Heliyon. 2023 Aug 22;9(9):e19233. doi: 10.1016/j.heliyon.2023.e19233. eCollection 2023 Sep. Heliyon. 2023. PMID: 37674842 Free PMC article. - Cellular reprogramming of fibroblasts in heart regeneration.
Chi C, Song K. Chi C, et al. J Mol Cell Cardiol. 2023 Jul;180:84-93. doi: 10.1016/j.yjmcc.2023.03.009. Epub 2023 Mar 23. J Mol Cell Cardiol. 2023. PMID: 36965699 Free PMC article. Review. - Transplant Tolerance, Not Only Clonal Deletion.
Hall BM, Verma ND, Tran GT, Hodgkinson SJ. Hall BM, et al. Front Immunol. 2022 Apr 21;13:810798. doi: 10.3389/fimmu.2022.810798. eCollection 2022. Front Immunol. 2022. PMID: 35529847 Free PMC article. Review. - iPSC Therapy for Myocardial Infarction in Large Animal Models: Land of Hope and Dreams.
Martínez-Falguera D, Iborra-Egea O, Gálvez-Montón C. Martínez-Falguera D, et al. Biomedicines. 2021 Dec 5;9(12):1836. doi: 10.3390/biomedicines9121836. Biomedicines. 2021. PMID: 34944652 Free PMC article. Review. - T cell receptor (TCR) signaling in health and disease.
Shah K, Al-Haidari A, Sun J, Kazi JU. Shah K, et al. Signal Transduct Target Ther. 2021 Dec 13;6(1):412. doi: 10.1038/s41392-021-00823-w. Signal Transduct Target Ther. 2021. PMID: 34897277 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials